These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26019047)

  • 1. Insights in non-alcoholic fatty liver disease pathophysiology with lipidomic analyses.
    Almeda-Valdes P; Altamirano-Barrera A; Méndez-Sánchez N
    Ann Hepatol; 2015; 14(4):567-9. PubMed ID: 26019047
    [No Abstract]   [Full Text] [Related]  

  • 2. Can NASH lipidome provide insight into the pathogenesis of obesity-related non-alcoholic fatty liver disease?
    Birerdinc A; Younossi Z
    J Hepatol; 2015 Apr; 62(4):761-2. PubMed ID: 25602593
    [No Abstract]   [Full Text] [Related]  

  • 3. Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity.
    Anjani K; Lhomme M; Sokolovska N; Poitou C; Aron-Wisnewsky J; Bouillot JL; Lesnik P; Bedossa P; Kontush A; Clement K; Dugail I; Tordjman J
    J Hepatol; 2015 Apr; 62(4):905-12. PubMed ID: 25450212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese.
    Aron-Wisnewsky J; Minville C; Tordjman J; Lévy P; Bouillot JL; Basdevant A; Bedossa P; Clément K; Pépin JL
    J Hepatol; 2012 Jan; 56(1):225-33. PubMed ID: 21703181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body mass index and the visceral adipose tissue expression of IL-6 and TNF-alpha are associated with the morphological severity of non-alcoholic fatty liver disease in individuals with class III obesity.
    Jorge ASB; Andrade JMO; Paraíso AF; Jorge GCB; Silveira CM; de Souza LR; Santos EP; Guimaraes ALS; Santos SHS; De-Paula AMB
    Obes Res Clin Pract; 2018; 12(Suppl 2):1-8. PubMed ID: 27083404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease.
    Cimini FA; Barchetta I; Carotti S; Bertoccini L; Baroni MG; Vespasiani-Gentilucci U; Cavallo MG; Morini S
    World J Gastroenterol; 2017 May; 23(19):3407-3417. PubMed ID: 28596677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of bariatric surgery on non-alcoholic fatty liver disease.
    Major P; Pędziwiatr M; Rubinkiewicz M; Stanek M; Głuszewska A; Pisarska M; Małczak P; Budzyński A; Budzyński P
    Pol Przegl Chir; 2017 Apr; 89(2):1-4. PubMed ID: 28537562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
    Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
    Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.
    Clemente MG; Mandato C; Poeta M; Vajro P
    World J Gastroenterol; 2016 Sep; 22(36):8078-93. PubMed ID: 27688650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
    Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
    World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.
    Praveenraj P; Gomes RM; Kumar S; Karthikeyan P; Shankar A; Parthasarathi R; Senthilnathan P; Rajapandian S; Palanivelu C
    Obes Surg; 2015 Nov; 25(11):2078-87. PubMed ID: 25835982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease.
    Luukkonen PK; Zhou Y; Sädevirta S; Leivonen M; Arola J; Orešič M; Hyötyläinen T; Yki-Järvinen H
    J Hepatol; 2016 May; 64(5):1167-1175. PubMed ID: 26780287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review of bariatric surgery liver biopsies clarifies the natural history of liver disease in patients with severe obesity.
    Bedossa P; Tordjman J; Aron-Wisnewsky J; Poitou C; Oppert JM; Torcivia A; Bouillot JL; Paradis V; Ratziu V; Clément K
    Gut; 2017 Sep; 66(9):1688-1696. PubMed ID: 27884920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of Non Alcoholic Fatty Liver Disease.
    Petta S; Gastaldelli A; Rebelos E; Bugianesi E; Messa P; Miele L; Svegliati-Baroni G; Valenti L; Bonino F
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27973438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingolipid metabolism in non-alcoholic fatty liver diseases.
    Régnier M; Polizzi A; Guillou H; Loiseau N
    Biochimie; 2019 Apr; 159():9-22. PubMed ID: 30071259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic steatohepatitis in children with severe obesity: A global concern.
    Xanthakos SA
    Surg Obes Relat Dis; 2017 Sep; 13(9):1609-1611. PubMed ID: 28935179
    [No Abstract]   [Full Text] [Related]  

  • 17. Considerations for bariatric surgery in patients with cirrhosis.
    Goh GB; Schauer PR; McCullough AJ
    World J Gastroenterol; 2018 Jul; 24(28):3112-3119. PubMed ID: 30065557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Liver Disease on Perioperative Outcome After Bariatric Surgery in a Northern German Cohort.
    Wolter S; Duprée A; Coelius C; El Gammal A; Kluwe J; Sauer N; Mann O
    Obes Surg; 2017 Jan; 27(1):90-95. PubMed ID: 27272667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound/Elastography techniques, lipidomic and blood markers compared to Magnetic Resonance Imaging in non-alcoholic fatty liver disease adults.
    Cantero I; Elorz M; Abete I; Marin BA; Herrero JI; Monreal JI; Benito A; Quiroga J; Martínez A; Huarte MP; Uriz-Otano JI; Tur JA; Kearney J; Martinez JA; Zulet MA
    Int J Med Sci; 2019; 16(1):75-83. PubMed ID: 30662331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors that predict the occurrence of and recovery from non-alcoholic fatty liver disease after pancreatoduodenectomy.
    Sato T; Matsuo Y; Shiga K; Morimoto M; Miyai H; Takeyama H
    Surgery; 2016 Aug; 160(2):318-30. PubMed ID: 27211602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.